Immunotherapy After Recent-Onset Type 1 Diabetes: Combinatorial Treatment for Achieving Long-Term Remission in Humans?

Editorial

Rev Diabet Stud, 2004, 1(3):108-112

DOI 10.1900/RDS.2004.1.108

Immunotherapy After Recent-Onset Type 1 Diabetes: Combinatorial Treatment for Achieving Long-Term Remission in Humans?

Damien Bresson, Matthias von Herrath

La Jolla Institute for Allergy and Immunology, Department of Developmental Immunology 3, 10355 Science Center Drive, San Diego, California 92121, USA.
Address correspondence to: Matthias von Herrath, e-mail: matthias@liai.org

Keywords: immunotherapy, anti-CD3, antigen-specific intervention, recent-onset type 1 diabetes, regulatory T cells

Abstract

n/a

Fulltext: HTML , PDF (230KB)

This article has been cited by other articles:

	An update on preventive and regenerative therapies in diabetes mellitus Reimann M, Bonifacio E, Solimena M, Schwarz PE, Ludwig B, Hanefeld M, Bornstein SR Pharmacol Ther 2009. 121(3):317-331

	Stopping diabetes in its tracks: autologous non-myeloablative stem cell transplantation Fousteri G, Hayek A, von Herrath M Regen Med 2007. 2(5): 845-851